Chung Bruce
Director · Officer · NRG, SJM
As of 2026-09-16, Chung Bruce has 42 Form 4 transactions on record across 2 companies — 27 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Pattern in the record: open-market sales filed in January in multiple years since 2025 — a recurring calendar cadence, more consistent with scheduled activity than a one-off decision.
Reconstructed holdings
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-01-07 | NRG | Sale | 7,383 @ $158.79 | $1.2M | −8.5% of holding | 79,147 | Form 4 |
| 2026-01-07 | NRG | Sale | 5,000 @ $153.25 | $766K | −5.5% of holding | 86,530 | Form 4 |
| 2026-01-06 | NRG | Sale | 7,617 @ $158.79 | $1.2M | −7.7% of holding | 91,530 | Form 4 |
| 2025-01-13 | NRG | Sale | 20,000 @ $97.63 | $2.0M | −22.4% of holding | 69,454 | Form 4 |
38 award / exercise / gift records — not counted as purchases
| Date | Company | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|
| 2026-08-03 | NRG | Award / grant | 55 | 89,647 | Form 4 |
| 2026-07-01 | SJM | Award / grant | 229 | 506 | Form 4 |
| 2026-06-05 | NRG | Option exercise | 22,328 | 0 | Form 4 |
| 2026-06-05 | NRG | Withheld for tax | 12,142 | 89,592 | Form 4 |
| 2026-06-05 | NRG | Option exercise | 1,410 | 103,001 | Form 4 |
| 2026-06-05 | NRG | Option exercise | 1,410 | 1,410 | Form 4 |
| 2026-06-05 | NRG | Withheld for tax | 1,267 | 101,734 | Form 4 |
| 2026-06-05 | NRG | Option exercise | 22,328 | 101,591 | Form 4 |
| 2026-05-01 | NRG | Award / grant | 57 | 79,263 | Form 4 |
| 2026-04-30 | NRG | Award / grant | 13,423 | 13,423 | Form 4 |
| 2026-04-01 | SJM | Award / grant | 275 | 275 | Form 4 |
| 2026-02-02 | NRG | Award / grant | 59 | 79,206 | Form 4 |
| 2026-02-02 | NRG | Award / grant | 59 | 79,206 | Form 4 |
| 2026-01-02 | NRG | Withheld for tax | 35,357 | 99,147 | Form 4 |
| 2026-01-02 | NRG | Option exercise | 5,114 | 137,739 | Form 4 |
| 2026-01-02 | NRG | Option exercise | 5,114 | 5,114 | Form 4 |
| 2026-01-02 | NRG | Withheld for tax | 3,516 | 134,504 | Form 4 |
| 2026-01-02 | NRG | Withheld for tax | 2,787 | 138,020 | Form 4 |
| 2026-01-02 | NRG | Withheld for tax | 1,558 | 140,807 | Form 4 |
| 2026-01-02 | NRG | Option exercise | 64,010 | 132,625 | Form 4 |
| 2026-01-02 | NRG | Award / grant | 4,626 | 142,365 | Form 4 |
| 2026-01-02 | NRG | Option exercise | 64,010 | 0 | Form 4 |
| 2026-01-02 | NRG | Award / grant | 9,393 | 9,393 | Form 4 |
| 2025-11-03 | NRG | Award / grant | 74 | 68,615 | Form 4 |
| 2025-08-01 | NRG | Award / grant | 77 | 68,539 | Form 4 |
| 2025-06-05 | NRG | Withheld for tax | 1,249 | 68,462 | Form 4 |
| 2025-05-01 | NRG | Award / grant | 122 | 69,711 | Form 4 |
| 2025-02-03 | NRG | Award / grant | 135 | 69,589 | Form 4 |
| 2025-01-02 | NRG | Option exercise | 19,810 | 0 | Form 4 |
| 2025-01-02 | NRG | Withheld for tax | 11,190 | 89,454 | Form 4 |
| 2025-01-02 | NRG | Withheld for tax | 2,495 | 100,644 | Form 4 |
| 2025-01-02 | NRG | Withheld for tax | 2,354 | 103,139 | Form 4 |
| 2025-01-02 | NRG | Option exercise | 2,066 | 106,413 | Form 4 |
| 2025-01-02 | NRG | Option exercise | 2,066 | 2,066 | Form 4 |
| 2025-01-02 | NRG | Withheld for tax | 920 | 105,493 | Form 4 |
| 2025-01-02 | NRG | Award / grant | 9,028 | 104,347 | Form 4 |
| 2025-01-02 | NRG | Option exercise | 19,810 | 95,319 | Form 4 |
| 2025-01-02 | NRG | Award / grant | 14,216 | 14,216 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.